EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:63583 - basiliximab
| ChEBI ID | CHEBI:63583 |
| ChEBI Name | basiliximab |
| Stars | |
| Definition | interleukin-2 receptor antagonist, binds a-chain of receptor complex and prevents interleukin-2 binding |
| Last Modified | 25 March 2020 |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| basiliximab (CHEBI:63583) has role anti-inflammatory agent (CHEBI:67079) |
| basiliximab (CHEBI:63583) has role antiinfective agent (CHEBI:35441) |
| basiliximab (CHEBI:63583) has role antineoplastic agent (CHEBI:35610) |
| basiliximab (CHEBI:63583) has role hypoglycemic agent (CHEBI:35526) |
| basiliximab (CHEBI:63583) has role ophthalmology drug (CHEBI:66981) |
| basiliximab (CHEBI:63583) has role renoprotective agent (CHEBI:231911) |
| basiliximab (CHEBI:63583) is a organic molecular entity (CHEBI:50860) |
| basiliximab (CHEBI:63583) is a unclassifieds (CHEBI:27189) |
| Synonyms | Source |
|---|---|
| Basiliximab | ChEMBL |
| CHI-621 | ChEMBL |
| SDZ-CHI-621 | ChEMBL |
| SDZCHI621 | ChEMBL |
| Brand Name | Source |
|---|---|
| Simulect | ChEMBL |